Spectral MD
About Spectral MD
Spectral MD, Inc. is a predictive analytics company that develops proprietary AI algorithms and optical technology for wound healing predictions. Using its DeepView® Wound Imaging Solution, an internally developed AI technology and multispectral imaging system which has received FDA Breakthrough Designation for the burn indication, Spectral MD is able to distinguish between non-healing and healing human tissue invisible to the naked eye. Spectral MD is working towards providing 'Day One' healing assessments for burn wounds and diabetic foot ulcers (DFU) using its DeepView® Wound Imaging Solution.
Company Metrics
- Employees: 51-100
- Monthly Visits: 3624
- Tech Stack: 8 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 100900000 USD
- Last Funding: 8200000 USD (Grant)
- Funding Status: IPO
Technology Stack
Spectral MD actively uses 8 products in their tech stack.
Market Presence
Industries: Analytics, Artificial Intelligence, Biotechnology, Health Care, Medical Device
Headquarters: Dallas, Texas, United States
Leadership
- Wensheng Fan - CEO, Co-Founder LinkedIn
Employees
- Nils Windler - Chief Financial Officer (LinkedIn)